Little ACF (Lilla ABC): Evaluation of a Parental Support Program for Parents of Children Aged 1-2 Years
Launched by KAROLINSKA INSTITUTET · Jun 30, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Little ACF (Lilla ABC) trial is studying a new program designed to support parents of young children aged 1-2 years. This program, called Little ACF, aims to help parents improve their parenting skills and enhance their children's social and emotional development. The trial is looking for parents who are registered at specific child health centers (CHCs) to participate. If you join, you will be randomly assigned to either the Little ACF program, which includes four group meetings, or a regular program that consists of a lecture and existing support options.
As a participant, you can expect to fill out questionnaires before, during, and after the Little ACF sessions to help researchers understand how the program affects you and your child. The goal is to gather important information that can help improve mental health support for families with young children. This study is open to all parents, but if you need an interpreter, you won't be able to participate. Your involvement could contribute to valuable insights that benefit many families in the future!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Parents of children in the age of 1-2 years that are registered at the CHCs included in the study
- Exclusion Criteria:
- • Parents in need of interpreter will be excluded
About Karolinska Institutet
Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vaxholm, , Sweden
Stockholm, , Sweden
Patients applied
Trial Officials
Lene Lindberg, Ass Prof
Principal Investigator
Karolinska Institutet
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials